NZ510446A - Gastrointestinal delivery of LH-RH peptide analogues - Google Patents

Gastrointestinal delivery of LH-RH peptide analogues

Info

Publication number
NZ510446A
NZ510446A NZ510446A NZ51044699A NZ510446A NZ 510446 A NZ510446 A NZ 510446A NZ 510446 A NZ510446 A NZ 510446A NZ 51044699 A NZ51044699 A NZ 51044699A NZ 510446 A NZ510446 A NZ 510446A
Authority
NZ
New Zealand
Prior art keywords
peptide analogues
gastrointestinal delivery
cyclodextrin
alpha
pharmaceutical compositions
Prior art date
Application number
NZ510446A
Other languages
English (en)
Inventor
Remi Delansorne
Paule Bonnet
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NZ510446A publication Critical patent/NZ510446A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
NZ510446A 1998-09-30 1999-09-23 Gastrointestinal delivery of LH-RH peptide analogues NZ510446A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (en) 1998-09-30 1998-09-30 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
PCT/EP1999/007389 WO2000018423A1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Publications (1)

Publication Number Publication Date
NZ510446A true NZ510446A (en) 2003-01-31

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510446A NZ510446A (en) 1998-09-30 1999-09-23 Gastrointestinal delivery of LH-RH peptide analogues

Country Status (28)

Country Link
EP (2) EP0998940A1 (xx)
JP (1) JP4485060B2 (xx)
KR (1) KR100652457B1 (xx)
CN (1) CN1200727C (xx)
AR (1) AR023056A1 (xx)
AT (1) ATE218358T1 (xx)
AU (1) AU756233B2 (xx)
BR (1) BR9914125A (xx)
CA (1) CA2344470C (xx)
CZ (1) CZ302343B6 (xx)
DE (1) DE69901721T2 (xx)
DK (1) DK1117420T3 (xx)
EE (1) EE04872B1 (xx)
ES (1) ES2178478T3 (xx)
HK (1) HK1042047B (xx)
HU (1) HUP0103649A3 (xx)
ID (1) ID28650A (xx)
IL (2) IL142112A0 (xx)
MX (1) MXPA01003340A (xx)
NO (1) NO330234B1 (xx)
NZ (1) NZ510446A (xx)
PL (1) PL200693B1 (xx)
PT (1) PT1117420E (xx)
RU (1) RU2214270C2 (xx)
SI (1) SI1117420T1 (xx)
TR (1) TR200100887T2 (xx)
WO (1) WO2000018423A1 (xx)
ZA (1) ZA200102452B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
ES2221019T3 (es) * 1996-10-31 2004-12-16 Takeda Chemical Industries, Ltd. Preparacion de liberacion mantenida.
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU6199999A (en) 2000-04-17
HK1042047B (zh) 2005-12-16
NO330234B1 (no) 2011-03-07
HUP0103649A2 (hu) 2002-02-28
AR023056A1 (es) 2002-09-04
CN1324241A (zh) 2001-11-28
DE69901721D1 (de) 2002-07-11
EE200100196A (et) 2002-06-17
CN1200727C (zh) 2005-05-11
EP0998940A1 (en) 2000-05-10
NO20011576L (no) 2001-03-28
PT1117420E (pt) 2002-10-31
NO20011576D0 (no) 2001-03-28
MXPA01003340A (es) 2004-04-21
BR9914125A (pt) 2001-06-19
IL142112A0 (en) 2002-03-10
RU2214270C2 (ru) 2003-10-20
ATE218358T1 (de) 2002-06-15
AU756233B2 (en) 2003-01-09
DE69901721T2 (de) 2003-01-09
KR20010075255A (ko) 2001-08-09
CZ20011173A3 (cs) 2001-09-12
ES2178478T3 (es) 2002-12-16
ID28650A (id) 2001-06-21
CA2344470A1 (en) 2000-04-06
CA2344470C (en) 2009-01-06
HUP0103649A3 (en) 2002-05-28
PL200693B1 (pl) 2009-01-30
PL346939A1 (en) 2002-03-11
DK1117420T3 (da) 2002-09-16
ZA200102452B (en) 2002-03-26
JP2002525336A (ja) 2002-08-13
TR200100887T2 (tr) 2001-10-22
IL142112A (en) 2006-10-31
WO2000018423A1 (en) 2000-04-06
KR100652457B1 (ko) 2006-11-30
SI1117420T1 (en) 2002-12-31
EP1117420B1 (en) 2002-06-05
JP4485060B2 (ja) 2010-06-16
CZ302343B6 (cs) 2011-03-23
EP1117420A1 (en) 2001-07-25
EE04872B1 (et) 2007-08-15

Similar Documents

Publication Publication Date Title
HUP0204137A2 (hu) Fulvesztrantot tartalmazó gyógyászati készítmény
MY118371A (en) Tetrahydrolipstatin containing compositions
DK0949907T3 (da) Fremgangsmåder og præparater til forbedret biotilgængelighed og biologisk aktive midler til slimhindeadministration
HK1036969A1 (en) Compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
HK1050839A1 (en) Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
AU2274201A (en) Compounds and compositions for delivering active agents
HUP0302319A2 (hu) Gyógyszerkészítmények gyógyászati hatóanyagok szájon át történő bejuttatására
WO2001052894A3 (en) Nasally administrable cyclic peptide compositions
CA2360220A1 (en) Oxadiazole compounds and compositions for delivering active agents
GR3019479T3 (en) Pharmaceutical compositions for transmucosal delivery of peptides.
IL161500A0 (en) Taste masking spill-resistant formulation
NZ237930A (en) Wafer for administration of medicaments through the sub-lingual mucosa
IL161670A0 (en) Thymosin alpha 1 peptide/polymer conjugates
HUP0203721A2 (hu) Új hormonkészítmény és alkalmazása
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
AU7723700A (en) Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
NZ510446A (en) Gastrointestinal delivery of LH-RH peptide analogues
PL348202A1 (en) Pharmaceutically active composition and dispensing device
WO2005018657A3 (en) NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
WO2005019457A3 (en) NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
HUP9904320A3 (en) Pharmaceutical compositions of weak acid drugs for colonic delivery
DE60042057D1 (de) Bukkales verabreichungssystem für proteinhaltige medikamente
WO2005019448A3 (en) NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed